Literature DB >> 30401479

Prospective validation of the safety of a laparoscopic cholecystectomy training paradigm featuring incremental autonomy.

Tarik D Madni1, Evan Barrios2, Jonathan B Imran3, Luis Taveras4, Audra T Clark5, Holly B Cunningham6, Alana Christie7, Stephen Luk8, Herb A Phelan9, Michael W Cripps10.   

Abstract

BACKGROUND: Surgical training is under scrutiny for the effect increased resident autonomy may have on patient outcomes. We hypothesize that as laparoscopic cholecystectomy (LC) difficulty increases, there will be increased involvement by senior residents and attending physicians with no differences in complications.
METHODS: Ten acute care surgeons were asked to fill out a postoperative questionnaire regarding surgical difficulty after every LC between 11/9/2016 and 3/30/2017. Either the Jonckheere-Terpstra test, Mantel-Haenzel chi square test, or ANOVA was used to test for the association between perioperative data and surgical difficulty.
RESULTS: A total of 190 LCs were analyzed. PGY level, percent of surgery time with attending surgeon involvement, partial cholecystectomy rate, and length of operation all significantly rose with increasing level of difficulty (p < 0.001) with no significant differences in 60-day emergency room bounce-backs, readmission, or complication rates.
CONCLUSIONS: We found that as LC difficulty increases, so does attending surgeon and/or senior resident involvement, without increased morbidity.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autonomy; Gallbladder; Laparoscopic cholecystectomy; Resident; Training

Mesh:

Year:  2018        PMID: 30401479     DOI: 10.1016/j.amjsurg.2018.10.043

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  1 in total

1.  The long game: Evolution of clinical decision making throughout residency and fellowship.

Authors:  Ingrid A Woelfel; Brentley Q Smith; Ritu Salani; Alan E Harzman; Amalia L Cochran; Xiaodong Phoenix Chen
Journal:  Am J Surg       Date:  2021-03-18       Impact factor: 3.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.